The Sartans Market is projected to witness steady growth through 2034, driven by the increasing prevalence of hypertension, cardiovascular diseases, and chronic kidney disorders worldwide. Sartans, also known as angiotensin II receptor blockers (ARBs), are widely prescribed for blood pressure management due to their efficacy and favorable safety profile compared to other antihypertensive drugs....